Login / Signup
Desulfovibrio vulgaris interacts with novel gut epithelial immune receptor LRRC19 and exacerbates colitis.
Runxiang Xie
Yu Gu
Mengfan Li
Lingfeng Li
Yunwei Yang
Yue Sun
Bingqian Zhou
Tianyu Liu
Sinan Wang
Wentian Liu
Rongcun Yang
Xiaomin Su
Weilong Zhong
Bangmao Wang
Hailong Cao
Published in:
Microbiome (2024)
D. vulgaris could promote colitis through DVF-LRRC19 interaction. Targeting DVF-LRRC19 interaction might be a new therapeutic strategy for UC therapy. Video Abstract.
Keyphrases
</>
ulcerative colitis
binding protein
cancer therapy
mesenchymal stem cells
drug delivery